Sanofi will continue to provide strong scientific and medical support to Emcure's already well-established and fast growing oncology business.
Drug firm Sanofi has entered into a marketing and distribution agreement with Emcure Pharmaceuticals for its oncology portfolio in India. As per the agreement, Sanofi will continue to own its oncology range comprising four brands namely Taxotere, Jevtana, Fludara and Fasturtec, while Emcure will market and distribute these brands through its specialty unit, Sanofi India said in a filing to the BSE.
"Realising that managing the complexities of cancer necessitates the availability of a wide range of products and supporting therapies, we found that combining our efforts and product range with that of Emcure Oncology, makes immense sense for both companies," Sanofi Vice-President-South Asia and Sanofi India Managing Director Shailesh Ayyangar said. Sanofi will continue to provide strong scientific and medical support to Emcure's already well-established and fast growing oncology business, he added.
Emcure Pharmaceuticals Managing Director Satish Mehta said: "We believe that the coming together of Sanofi's innovative oncology range with Emcure's oncology portfolio empowers us to provide an even wider array of value driven healthcare solutions." Sanofi India Ltd shares were trading at Rs 2,886 a piece on the BSE in afternoon trade, up 0.27 percent from its previous close.
Sanofi India stock price
On August 06, 2014, at 14:11 hrs Sanofi India was quoting at Rs 2900.00, up Rs 21.80, or 0.76 percent. The 52-week high of the share was Rs 3540.00 and the 52-week low was Rs 2280.00.
The company's trailing 12-month (TTM) EPS was at Rs 121.06 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 23.96. The latest book value of the company is Rs 584.74 per share. At current value, the price-to-book value of the company is 4.96.
Anda sedang membaca artikel tentang
Sanofi inks marketing pact with Emcure for cancer drugs
Dengan url
https://kesehatanda.blogspot.com/2014/08/sanofi-inks-marketing-pact-with-emcure.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Sanofi inks marketing pact with Emcure for cancer drugs
namun jangan lupa untuk meletakkan link
Sanofi inks marketing pact with Emcure for cancer drugs
sebagai sumbernya
0 komentar:
Posting Komentar